ArticleActa pharmacologica Sinica2025

Targeting PPARα activation sensitizes glioblastoma cells to temozolomide and reverses acquired resistance by inhibiting H3K18 lactylation.

Zhen-Chuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.